Daniel J. Lippis is CVP, JAPAC of Edwards Lifesciences Corp. Currently has a direct ownership of 22,588 shares of EW, which is worth approximately $1.64 Million. The most recent transaction as insider was on Feb 18, 2024, when has been sold 188 shares (Common Stock) at a price of $86.1 per share, resulting in proceeds of $16,186. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K
2.59% 3M change
31.23% 12M change
Total Value Held $1.64 Million

Daniel J. Lippis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2024
SELL
Payment of exercise price or tax liability
$16,186 $86.1 p/Share
188 Reduced 1.08%
17,213 Common Stock
Feb 17 2024
SELL
Payment of exercise price or tax liability
$12,915 $86.1 p/Share
150 Reduced 0.85%
17,401 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$17,810 $86.04 p/Share
207 Reduced 1.17%
17,551 Common Stock
DJL

Daniel J. Lippis

CVP, JAPAC
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW